Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder

Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03602157	Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL	active not recruiting	Phase 1	43	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Jun 12, 2026	clinicaltrials
NCT01134341	Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma	completed	Phase 1	34	Acrotech Biopharma Inc.INDUSTRY	2	Dec 18, 2019	clinicaltrials